The risk prediction of development of neuroleptic hyperprolactinemia based on genetic markers

D. Osmanova, M. Freidin, O. Fedorenko, A. Loonen, S. Ivanova

Research output: Contribution to journal › Meeting Abstract

Original language	English
Pages (from-to)	S409-S409
Journal	European Neuropsychopharmacology
Volume	29
DOIs	https://doi.org/10.1016/j.euroneuro.2018.11.622
Publication status	Published - Feb 2019

Access to Document

@article{c9d80cae1fd84d628d575c491f424ba1,

title = "The risk prediction of development of neuroleptic hyperprolactinemia based on genetic markers",

author = "D. Osmanova and M. Freidin and O. Fedorenko and A. Loonen and S. Ivanova",

year = "2019",

month = feb,

doi = "10.1016/j.euroneuro.2018.11.622",

language = "English",

volume = "29",

pages = "S409--S409",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier",

}

TY - JOUR

T1 - The risk prediction of development of neuroleptic hyperprolactinemia based on genetic markers

AU - Osmanova, D.

AU - Freidin, M.

AU - Fedorenko, O.

AU - Loonen, A.

AU - Ivanova, S.

PY - 2019/2

Y1 - 2019/2

U2 - 10.1016/j.euroneuro.2018.11.622

DO - 10.1016/j.euroneuro.2018.11.622

M3 - Meeting Abstract

SN - 0924-977X

VL - 29

SP - S409-S409

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

ER -